Debunking myths on genetics and DNA

Monday, January 30, 2012

The wondrous mitochondrion and its proteome


The sequencing of human mitochondrial DNA, a circular DNA molecule contained in mitochondria, was completed in 1981, and, since then, roughly 150 mutations have been found that are associated with maternally inherited diseases (if you don't remember why mtDNA is inherited from the mother and not the father, check out this earlier post of mine). Despite this, the majority of human mitochondrial syndromes are actually caused by defects in the nuclear genome. This is sort of obvious if you think about it, given that human mitochondrial proteome consists of an estimated 1,100-1,400 distinct proteins, of which 13 are encoded by the mitochondrial DNA. The majority of proteins targeted at the mitochondria are actually encoded by nuclear genes. In fact
"The 13 proteins encoded by mammalian mtDNA are all components of the respiratory chain, which generates the majority of cellular ATP via oxidative phosphorylation (OXPHOS). However, the remaining respiratory chain subunits are encoded by nuclear genes, as are all proteins required for the transcription, translation, modification, and assembly of the 13 mtDNA proteins. All the components of numerous other mitochondrial pathways are also nuclear en- coded, including the tricarboxylic acid (TCA) cycle, protein import, fatty acid and amino acid oxidation, apoptosis, and biosynthesis of ketone bodies, pyrimidines, heme, and urea. Furthermore, during the decades following the sequencing of the mtDNA, it became clear that maternally inherited mitochondrial disorders represent only 20% of all inherited human mitochondrial disorders [1]."
Mitochondria are amazing organelles. Roughly half of mitochondrial proteins are ubiquitous and found across all organs, while the rest are tissue specific, meaning that their function and structure varies across cell lines. For example, when comparing mitochondria across different tissues, researchers found about a 75% overlap. In addition to this cell-type specificity, some of the mitochondrial proteins are expressed at very low levels or only during certain specific developmental stages, making the characterization of the mitochondrial proteome a challenging task. Today, a little over 1,000 of all mitochondrial proteins have been identified, mainly through large-scale proteomics, microscopy, and computation.

The first half of Calvo and Mootha's review [1] is an detailed report on the progress made so far in extensively classifying the mitochondrial proteome. They then proceed to discuss how the inventory of mitochondrial proteins has lead to the better understanding of mitochondrial disorders as well as the discovery of new disease genes.
"Traditionally, mitochondrial disease has referred primarily to disorders of oxidative ATP production, as discussed above. However the breadth of the mitochondrial proteome now implicates a large number of additional phenotypes, such as soft tissue tumors (paragangliomas) and diabetes mellitus. The discovery of new disease genes will further expand the clinical phenotypes associated with mitochondrial defects."

[1] Calvo, S., & Mootha, V. (2010). The Mitochondrial Proteome and Human Disease Annual Review of Genomics and Human Genetics, 11 (1), 25-44 DOI: 10.1146/annurev-genom-082509-141720

ResearchBlogging.org

8 comments:

  1. What's the origin of mitochondrial genes in the nuclear genome? Were they originally part of the mitochondrial genome? or evolved in the nuclear genome after mitochondrial capture? This is only peripherally related to your post, I know, but I thought I'd ask anyway, maybe another post? :)

    ReplyDelete
    Replies
    1. Hi Hollis, thanks for the excellent question. You're absolutely right, I should tackle that part -- basically how those genes originated after the symbiotic event that created mitochondria... Give me a few day sand I'll put something together! :)

      Thanks!

      Delete
    2. Found a paper titled "How do mitochondrial genes get into the nucleus?" :) Will discuss it soon!

      Delete
  2. thank you! and nice leaf photo :)

    ReplyDelete
  3. EEGiorgi, Again a very nice post. I was wondering lately about the origin of de DNA code and how it evolved. It seems originally there existed two codes where codons were determined by just two bases. This theory is based on the fact that there exist two different types of tRNA's each of which 'take care' of 10 aminoacids. http://arxiv.org/pdf/q-bio/0403036v2.pdf

    It seems some traces of this story are still found in mitochondria since they have a different simpler code than nuclear DNA.
    Do you have a blog about this already or otherwise could you send me a link about this subject. I blogged about the evolution of the code and get a lot of questions I am not able to answer...
    Thank you very much,

    ReplyDelete
    Replies
    1. Wow, I'm so honored to get such challenging questions! Like I told Hollis, this is definitely material for a new post. Give me a couple of weeks to put something together -- is that okay? I usually schedule my posts ahead of time so the next few posts will be completely different (because I've already scheduled them), but that doesn't mean I've forgotten!

      Again, many thanks for your question, Marleen.

      Delete
  4. Hello there! You have such an interesting and informative page. I will be looking forward to visit your page again and for your other posts as well. Thank you for sharing your thoughts about proteomics services in your area. I am glad to stop by your site and know more about proteomics services. Keep it up! This is a good read.
    Because protein phosphorylation is one of the most-studied protein modifications, many "proteomic" efforts are geared to determining the set of phosphorylated proteins in a particular cell or tissue-type under particular circumstances. This alerts the scientist to the signaling pathways that may be active in that instance.
    The PS Biomarker ServicesTM Protein TMT-SRM work flow uses the high selectivity and sensitivity of Selected Reaction Monitoring (SRM) Mass Spectrometry combined with isobaric and isotopic forms of TMT labeling to deliver seamless integration of biomarker discovery and targeted assay development workflows without the need to synthesise expensive AQUA peptides. TMT-SRM methods can be developed for tens to hundreds of candidate biomarkers within a few days of completing discovery studies. After qualification a final biomarker panel can be transferred for absolute quanitative assay development by SRM or immunoassay.

    Proteomics Services

    ReplyDelete

Comments are moderated. Comments with spam links will be deleted and never published. So, if your intention is to leave a comment just to post a bogus link, please spare your time and mine. To all others: thank you for leaving a comment, I will respond as soon as possible.